Tulsa-based Schusterman Interests acquired 1,939,201 shares of HeartFlow valued at $65.3 million in the third quarter, making it the fund’s fourth-largest holding. The fund’s 13F assets under management include HeartFlow as 14.9% of total assets. The acquisition reflects a significant new allocation in the fund’s portfolio.

Schusterman Interests disclosed a new $65.3 million position in HeartFlow, acquiring 1.9 million shares in the third quarter. HeartFlow now represents 14.9% of the fund’s assets, making it the fourth-largest holding. The stock’s price has surged about 70% from its $19 IPO price.

HeartFlow, a healthcare technology company, specializes in non-invasive diagnostic tools for coronary artery disease. Leveraging AI and computational modeling, it aims to enhance clinical decision-making and patient outcomes. The company generates revenue primarily from its proprietary AI-powered platform for managing coronary artery disease.

Billionaire-backed Schusterman Interests initiated a $65.3 million position in HeartFlow during the third quarter, acquiring 1.9 million shares. This move reflects confidence in the company’s technology and potential for revenue growth. HeartFlow’s shares have surged approximately 70% from their IPO price, attracting long-term investors.

The Motley Fool highlights three “Double Down” stock recommendations, including Nvidia, Apple, and Netflix, which have seen significant returns for early investors. These alerts are available through Stock Advisor, offering a unique opportunity to invest in promising companies before they reach their full potential.

Read more at Yahoo Finance: Billionaire Family Office Acquires $65 Million of HeartFlow as Stock Jumps 70% From IPO